Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Sauerberg

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Lipid Research|March 5, 2004
Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profilesKlaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg, et al.
European Journal of Pharmacology|October 13, 2009
Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db miceMaria Sörhede Winzell, Erik Max Wulff, Grith Skytte Olsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
European Journal of Pharmacology|September 2, 2008
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazonePhilip J Larsen, Kirsten Lykkegaard, Leif K Larsen, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Selective PPAR agonists for the treatment of type 2 diabetesJan O Nehlin, John P Mogensen, Ingrid Petterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships of dimeric PPAR agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 12, 2002
Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF ratsChristian L Brand, Jeppe Sturis, Carsten F Gotfredsen, et al.
Plos One|March 4, 2022
Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfallsLotte Simonsen, Jesper Lau, Thomas Kruse, et al.
Journal of Medicinal Chemistry|April 4, 2003
Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazarSøren Ebdrup, Ingrid Pettersson, Hanne B Rasmussen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Lipid Research|March 5, 2004
Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profilesKlaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg, et al.
European Journal of Pharmacology|October 13, 2009
Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db miceMaria Sörhede Winzell, Erik Max Wulff, Grith Skytte Olsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Novel selective PPARdelta agonists: optimization of activity by modification of alkynylallylic moietyMiroslav Havranek, Per Sauerberg, John P Mogensen, et al.
European Journal of Pharmacology|September 2, 2008
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazonePhilip J Larsen, Kirsten Lykkegaard, Leif K Larsen, et al.
Annals of the New York Academy of Sciences|June 29, 2006
Selective PPAR agonists for the treatment of type 2 diabetesJan O Nehlin, John P Mogensen, Ingrid Petterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships of dimeric PPAR agonistsPer Sauerberg, John P Mogensen, Lone Jeppesen, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Design of a partial PPARdelta agonistIngrid Pettersson, Søren Ebdrup, Miroslav Havranek, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 12, 2002
Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF ratsChristian L Brand, Jeppe Sturis, Carsten F Gotfredsen, et al.
Plos One|March 4, 2022
Preclinical evaluation of a protracted GLP-1/glucagon receptor co-agonist: Translational difficulties and pitfallsLotte Simonsen, Jesper Lau, Thomas Kruse, et al.
Journal of Medicinal Chemistry|April 4, 2003
Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazarSøren Ebdrup, Ingrid Pettersson, Hanne B Rasmussen, et al.
Pageof 2